Patrícia Machado Pinto

Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults

Marília Santini-Oliveira, Rhea N. Coler, Jucara F. C. Parra et al. · Vaccine · 2015 · 114 citations

Vaccination, Vaccine Safety, Vaccine Development +10

Genetic variability analysis among clinical Candida spp. isolates using random amplified polymorphic DNA

Patrícia Machado Pinto, Maria Aparecida de Resende, Cristiane Yumi Koga‐Ito et al. · Memórias do Instituto Oswaldo Cruz · 2004 · 31 citations · Full text

Genetics, Genetic Epidemiology, Clinical Mycology +19

In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis

Patrícia Machado Pinto, Rita de Cássia Botelho Weikert-Oliveira, Juliana Pereira Lyon et al. · Microbiological Research · 2006 · 25 citations

Antifungal Agent, Antifungal Agents, Candida Spp +9

rDNA-RFLP identification of<i>Candida</i>species in immunocompromised and seriously diseased patients

Patrícia Machado Pinto, Maria Aparecida de Resende, Cristiane Yumi Koga‐Ito et al. · Canadian Journal of Microbiology · 2004 · 23 citations

Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women

Marília Santini-Oliveira, Patrícia Machado Pinto, Tatiane dos Santos et al. · Vaccines · 2022 · 21 citations · Full text